U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07053917) titled 'Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability' on May 30.
Brief Summary: The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Stroke
Chronic Stroke
Intracerebral Haemorrhage
Intracerebral Haemorrhage (ICH)
Intracerebral Hemorrhage Basal Ganglia
Ischemic Stroke
Ischemic Stroke and Hemorrhagic Stroke
Hemiparesis After Stroke
Hemiplegia Following Ischemic Stroke
Hemiplegia and Hemiparesis
Hemiplegia and/or Hemiparesis Following Stroke
Middle Cerebral Artery Stroke
Int...